top of page
  • Conferences
    • Sep 1, 2022

#IMS2022 - 19th International Myeloma Society Annual Meeting; Aug 25-27, LA California

Updated: Sep 16, 2022

Symplur

The #IMS2022 Influencers


#IMS2022 - 19th International Myeloma Society Annual Meeting; Aug 25-27, LA California


#IMS2022 Myeloma Abstract E-Book

 

 

CART

 

NCT03361748 : KarMMa - Phase 2 - To Determine the Efficacy and Safety of bb2121 in refractory MM


KarMMa - bb2121 - Multiple Myeloma Clinical Trials (themyelomaclinicaltrials.com)

 

NCT03274219 : Phase 1 - bb21217 an Anti-BCMA CAR T Cell Drug Product, in RRMM - CRB-402